Lysozyme can directly bind and neutralize extracellular, prooxidant bioreactive derivatives, which are termed advanced glycation end products and are otherwise pro-inflammatory [136, 137]; however, this interaction also blocks the enzymatic bactericidal activity of lysozyme, which could have secondary effects on immune responses during infection [137]. The gene discussed is LYZ; the disease is infection.